launch
Verona Pharma Prepares $650 Million Funding Pool for Ensifentrine Launch Ahead of FDA Decision
Verona Pharma, COPD, Ensifentrine, FDA, funding pool, launch, clinical trials, chronic obstructive pulmonary disease
2 former Apple Tree investors roll toward new biotech-focused fund launching with $310M
Scion, launch, Scion Life Sciences